31 January 2023 | News
To advance the development of China's life sciences industry
image credit- getty images
Shanghai Duoning Biotechnology Co. has signed an agreement on the Transfer of the Right to Use State-owned Construction Land with the Bureau of Planning and Natural Resources of Fengxian District, Shanghai and officially settled its global headquarters (HQ) in the Biotechnology Park of Shanghai Fengxian Economic Development Zone. Duoning will build a research and development (R&D) centre and a technology applications centre (TAC) based on the park's innovative vibe and clustering advantages.
The global headquarters, R&D centre, and TAC are located in the heart of the Biotechnology Park, with a total planned area of 20,029.8 m2. It is planned with an office building, an R&D testing centre, pilot plants, supporting utilities, etc.
The total construction area of the project will be over 40,000 m2. As a leading one-stop bioprocess solutions provider in China, the company is focused on providing comprehensive solutions for biological products from research to commercialisation and continues to empower the life sciences industry with its two major businesses, bioprocess solutions and lab products & services.
After signing the agreement, Duoning will provide research institutions, contract research organisations (CROs)/ contract development and manufacturing organisations (CDMOs), and pharmaceutical companies with equipment, consumables, and process-related services required for biologics research and manufacture based on the established biopharmaceutical industry cluster in the park.